What is Knopp Biosciences?
Knopp is an emerging life sciences company in Pittsburgh, PA, USA, committed to developing novel treatments for ALS and other neurodegenerative disorders. Our highest priority is demonstrating whether our lead compound, KNS-760704, is safe and effective as a treatment for ALS and, if so, to bring the medicine to the market as quickly as possible. Knopp is led by experienced pharmaceutical executives, neuroscientists, and entrepreneurs committed to addressing unmet medical needs. The company’s name honors the late Walter Knopp, a Pittsburgh entrepreneur and ALS patient whose visionary gift to the University of Pittsburgh supported the discovery of potential ALS biomarkers licensed by Knopp.
